The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome.
AUTOR(ES)
Ellis, M E
RESUMO
A review of 80 patients with the polymyalgia rheumatica/giant cell arteritis (PMR/GCA) syndrome has revealed that the erythrocyte sedimentation rate (ESR) is normal in 22.5% of cases at presentation. Too much reliance on the ESR as a screening test led to delay in diagnosis in 10 patients. Serious complications occurred in 4 patients with a normal or minimally raised ESR. Analysis of follow-up data at 4 weeks showed no significant correlation between change in the ESR and change in symptoms, and at subsequent clinical attendances symptoms did not consistently parallel the ESR. Our results cast serious doubts on the use of the ESR as an entirely reliable diagnostic and therapeutic aid in the PMR/GCA syndrome.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1001093Documentos Relacionados
- The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment.
- ESR in polymyalgia rheumatica and giant cell arteritis.
- Hepatocellular disease in the giant-cell arteritis/polymyalgia rheumatica syndrome.
- Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.
- Antibodies to intermediate filaments in polymyalgia rheumatica/giant cell arteritis: do they reflect the underlying disease activity rather than the acute phase response?
